Policy | June 14, 2022
COVID is not over yet, says Union Health Minister
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
Tislelizumab is now approved in nine indications in China
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Subscribe To Our Newsletter & Stay Updated
